Molecular Therapy Nucleic Acids Impact Factor, Indexing, Ranking 2024

Molecular Therapy Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic-acid-based therapeutics to treat and/or correct genetic and acquired disease. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy Nucleic Acids builds upon the success of Molecular Therapy in publishing important peer-reviewed research, cutting-edge reviews, and commentaries targeted to advances in gene- and oligonucleotide-based therapies.Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials.

《分子治疗核酸》是一本国际性、开放获取的期刊，致力于发表在核酸治疗领域的基础研究、转化研究和临床研究的高质量研究成果。该期刊作为美国基因与细胞治疗学会的官方出版物，承继了《分子治疗》在发表重要同行评审研究、前沿综述和评论方面的成功，专注于基因和寡核苷酸治疗领域的最新进展。涵盖的主题包括但不限于：基于核酸及其衍生物的治疗药物开发、RNA治疗药物的载体开发与设计、基因修饰剂（包括三链形成寡核苷酸和如锌指核酸酶等酶）的应用、临床前靶点验证、安全/有效性研究以及临床试验。